| 1 |
Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial |
|
| | Cheolmin Shin, Sang Won Jeon, Seung-Hoon Lee, Chi-Un Pae, Narei Hong, Hyun Kook Lim, Ashwin A. Patkar, Prakash S. Masand, Hyonggin An, Changsu Han | | | Clinical Psychopharmacology and Neuroscience. 2023; 21(1): 135 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
CYP2C19 polymorphisms and outcomes of Escitalopram treatment in Brazilians with major depression |
|
| | Rodrigo Bernini de Brito, Paulo César Ghedini | | | Heliyon. 2020; 6(5): e04015 | | | [Pubmed] [Google Scholar] [DOI] | |
|
